Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Peimine helps heal skin wounds by activating a specific cell signaling pathway.

The topical treatment with caffeine and Procapil 3% improved male pattern hair loss and was well tolerated after 12 weeks.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Finasteride is a medication used to treat hair loss and enlarged prostate.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Verteporfin with dermal wounding may boost hair regrowth in thinning areas but not in bald spots.

Both steroid treatments effectively regrow hair in severe alopecia areata.

PRP therapy is more effective and preferred over minoxidil for hair loss.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Tadalafil and Finasteride may help treat aggressive melanoma.

Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Bimatoprost can cause excessive eyelash growth.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.